[ad_1] – The Trastuzumab drug recently became popular because it was removed from the list of drugs covered by the Social Security Administrative Organ (SJBP). This cancer drug was suspended on April …
Read More »Trastuzumab triggered drug trigger, a cancer patient Jokowi and BPJS Health
[ad_1] TRIBUNJAKARTA.COM, JAKARTA A cancer patient named Juniarti suing President Joko Widodo and BPJS Health Edy Haryadi the husband filed a lawsuit due to the suspension of Trastuzumab's drug guarantees [19659002] and …
Read More »Roche launches breast cancer drugs, trastuzumab, with new formulations
[ad_1] Cancer Cells – PT Roche Indonesia has launched a new formulation for the treatment of bad cancer HER2 (Human Epidermal Growth Factor Receptor 2), at the Westin Hotel, Jakarta, Wednesday (11/7) …
Read More »Sebagian obat kanker trastuzumab tak dijamin BPJS, ini penjelasan dokter
[ad_1] Jakarta (ANTARA News) – Dokter Hematologi-Onkologi Medik Rumah Sakit Kanker Dharmais Dr. dr Nugroho Prayogo, SpPD-KHOM menjelaskan alasan sebagian obat kanker payudara trastuzumab tidak lagi dijamin dalam layanan Badan Penyelenggara Jaminan …
Read More »Trastuzumab subcutaneously
[ad_1] Jakarta, gatra.com – Biotech company, Roche has released a breakthrough treatment against bad cancer. Trastuzumab-based drugs, originally available only in intravenous infusion preparations, now develop into subcutaneous injections. This formulation alleviates …
Read More »Trastuzumab subcutaneous cancer side effects
[ad_1] JAKARTA, (PR) .- The bad cancer drug "Trastuzumab Subcutan" may be an alternative to other cancer drugs, Trastuzumab Intraven. As reported by Antara News Agency, Ph.D. in Hematology-Medical Oncology from Dharmais …
Read More »